Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-Type 1”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00000755
What this trial is testing

A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 168
Large-scale testing (Phase 3)WithdrawnNCT00719823
What this trial is testing

Maraviroc Compassionate Use

Who this might be right for
Human Immunodeficiency Virus Type 1
ViiV Healthcare
Testing effectiveness (Phase 2)Study completedNCT05630885
What this trial is testing

Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV

Who this might be right for
HIV-1-infectionElevated Cardiovascular Risk
National Institute of Allergy and Infectious Diseases (NIAID) 110
Early research (Phase 1)Study completedNCT00982579
What this trial is testing

Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers

Who this might be right for
HIV-1HIV Infections
Medical Research Council 48
Not applicableStudy completedNCT05294159
What this trial is testing

Implementing Long-Acting Novel Antiretrovirals

Who this might be right for
Human Immunodeficiency Viruses
Queen Mary University of London 114
Large-scale testing (Phase 3)Ended earlyNCT00144833
What this trial is testing

Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects

Who this might be right for
HIV-1
GlaxoSmithKline 150
Testing effectiveness (Phase 2)Study completedNCT02582684
What this trial is testing

Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 122
Post-approval studies (Phase 4)Study completedNCT00005764
What this trial is testing

Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients

Who this might be right for
HIV InfectionsLipodystrophy
Glaxo Wellcome 100
Not applicableStudy completedNCT00002426
What this trial is testing

A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients

Who this might be right for
HIV Infections
Gilead Sciences 390
Large-scale testing (Phase 3)Study completedNCT01479868
What this trial is testing

Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1

Who this might be right for
Hepatitis C Virus Genotype-1
Janssen R&D Ireland 109
Testing effectiveness (Phase 2)Study completedNCT00460382
What this trial is testing

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 103
Early research (Phase 1)Study completedNCT00613249
What this trial is testing

A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels

Who this might be right for
HIV Infections
International Partnership for Microbicides, Inc. 36
Not applicableStudy completedNCT05405582
What this trial is testing

Thetha Nami Ngithethe Nawe ("Let's Talk"): Step Wedge cRCT of Peer Led Community PrEP and SRH for Youth in South Africa

Who this might be right for
HIV-1-infectionSexually Transmitted Diseases
Africa Health Research Institute 8,716
Not applicableStudy completedNCT00351442
What this trial is testing

Examining Factors That May Influence Resistance to HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 522
Not applicableUnknownNCT03235310
What this trial is testing

Prospective Observational Cohort Study on Mother to Child Transmission HIV1/HIV2 and Prevention

Who this might be right for
Mother to Child Transmission of HIV
French National Agency for Research on AIDS and Viral Hepatitis 18,200
Testing effectiveness (Phase 2)Study completedNCT00380159
What this trial is testing

Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014A

Who this might be right for
Human Immunodeficiency Virus (HIV)-1 Infection
Alexion Pharmaceuticals, Inc. 4
Not applicableUnknownNCT05372510
What this trial is testing

Feasibility of Identifying, Enrolling and Following Acute and Early HIV-1 Infected Individuals.

Who this might be right for
Acute Human Immunodeficiency Virus Type I Infection
MRC/UVRI and LSHTM Uganda Research Unit 100
Post-approval studies (Phase 4)Looking for participantsNCT06646562
What this trial is testing

Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.

Who this might be right for
HIV-1 Infected Adults with Controlled Viremia
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 120
Early research (Phase 1)Study completedNCT06031272
What this trial is testing

Pausing Antiretroviral Treatment Under Structured Evaluation

Who this might be right for
HIV-1-infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 32
Large-scale testing (Phase 3)Study completedNCT00670839
What this trial is testing

Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)

Who this might be right for
Hepatitis BHIV Infection
ANRS, Emerging Infectious Diseases 178
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation